Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Real-Time Price · USD
168.92
+4.68 (2.85%)
Feb 20, 2026, 4:00 PM EST - Market closed
CRL Revenue
In the year 2025, Charles River Laboratories International had annual revenue of $4.02B, down -0.85%. Charles River Laboratories International had revenue of $994.23M in the quarter ending December 27, 2025, a decrease of -0.83%.
Revenue (ttm)
$4.02B
Revenue Growth
-0.85%
P/S Ratio
2.07
Revenue / Employee
$203,826
Employees
19,700
Market Cap
8.32B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 27, 2025 | 4.02B | -34.61M | -0.85% |
| Dec 28, 2024 | 4.05B | -79.42M | -1.92% |
| Dec 30, 2023 | 4.13B | 153.35M | 3.86% |
| Dec 31, 2022 | 3.98B | 435.90M | 12.31% |
| Dec 25, 2021 | 3.54B | 616.23M | 21.08% |
| Dec 26, 2020 | 2.92B | 302.71M | 11.55% |
| Dec 28, 2019 | 2.62B | 355.13M | 15.67% |
| Dec 29, 2018 | 2.27B | 408.50M | 21.99% |
| Dec 30, 2017 | 1.86B | 176.17M | 10.48% |
| Dec 31, 2016 | 1.68B | 318.13M | 23.34% |
| Dec 26, 2015 | 1.36B | 65.64M | 5.06% |
| Dec 27, 2014 | 1.30B | 132.13M | 11.34% |
| Dec 28, 2013 | 1.17B | 36.00M | 3.19% |
| Dec 29, 2012 | 1.13B | -13.12M | -1.15% |
| Dec 31, 2011 | 1.14B | 9.23M | 0.81% |
| Dec 25, 2010 | 1.13B | -38.23M | -3.26% |
| Dec 26, 2009 | 1.17B | -123.66M | -9.55% |
| Dec 27, 2008 | 1.30B | 64.67M | 5.26% |
| Dec 29, 2007 | 1.23B | 172.24M | 16.27% |
| Dec 30, 2006 | 1.06B | 65.06M | 6.55% |
| Dec 31, 2005 | 993.33M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Quest Diagnostics | 11.04B |
| ICON Public Limited Company | 8.10B |
| Illumina | 4.34B |
| Exact Sciences | 3.25B |
| Revvity | 2.86B |
| Medpace Holdings | 2.53B |
| Qiagen | 2.09B |
| RadNet | 1.97B |
CRL News
- 3 days ago - Charles River Laboratories International, Inc. (CRL) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 3 days ago - Charles River Laboratories Q4 Review: Approaching A Bottom - Seeking Alpha
- 3 days ago - Charles River forecasts upbeat 2026 profit on improved demand for drug development services - Reuters
- 3 days ago - Charles River Laboratories Announces Executive Appointments - Business Wire
- 3 days ago - Charles River Laboratories Announces Fourth-Quarter and Full-Year 2025 Results and Provides 2026 Guidance - Business Wire
- 9 days ago - Halper Sadeh LLC Encourages Charles River Laboratories International, Inc. Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewsWire
- 4 weeks ago - Charles River Laboratories Schedules Fourth-Quarter 2025 Earnings and 2026 Guidance Release and Conference Call - Business Wire
- 4 weeks ago - Charles River Enters Manufacturing Collaboration with Gazi University - Business Wire